title: Heart rate: a forgotten link in coronary artery disease?
abstract: A considerable body of evidence indicates that elevated resting heart rate is an independent, modifiable risk factor for cardiovascular events and mortality in patients with coronary artery disease. Elevated heart rate can produce adverse effects in several ways. Firstly, myocardial oxygen consumption is increased at high heart rates, but the time available for myocardial perfusion is reduced, increasing the likelihood of myocardial ischemia. Secondly, exposure of the large elastic arteries to cyclical stretch is increased at high heart rates. This effect can increase the rate at which components of the arterial wall deteriorate. Elastin fibers, which have an extremely slow rate of turnover in adult life, might be particularly vulnerable. Thirdly, elevated heart rate can predispose the myocardium to arrhythmias, and favor the development and progression of coronary atherosclerosis, by adversely affecting the balance between systolic and diastolic flow. Comparisons of the effects of the specific heart-rate-lowering drug ivabradine with those of β-blockers could help clarify the pathophysiological effects of elevated heart rate. Effective heart rate control among patients with coronary artery disease is uncommon in clinical practice, representing a missed therapeutic opportunity.
authors.affiliation: Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. k.fox@rbht.nhs.uk
authors.forename: Kim M
authors.initials: KM
authors.lastname: Fox
authors.forename: Roberto
authors.initials: R
authors.lastname: Ferrari
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000473:pathology; D001161:Arteriosclerosis / Q000473:pathology; D001552:Benzazepines / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000473:pathology*; D003331:Coronary Vessels / Q000473:pathology*; D018450:Disease Progression; D004548:Elasticity; D004730:Endothelium, Vascular / Q000473:pathology; D006339:Heart Rate / Q000502:physiology*; D006439:Hemodynamics; D006801:Humans; D000077550:Ivabradine; D017202:Myocardial Ischemia; D009206:Myocardium; D010101:Oxygen Consumption
chemical_list: D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D000077550:Ivabradine